Cargando…
Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
BACKGROUND: Prediction of patient survival from tumor molecular ‘-omics’ data is a key step toward personalized medicine. Cox models performed on RNA profiling datasets are popular for clinical outcome predictions. But these models are applied in the context of “high dimension”, as the number p of c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533541/ https://www.ncbi.nlm.nih.gov/pubmed/36199072 http://dx.doi.org/10.1186/s12885-022-10117-1 |
_version_ | 1784802368801472512 |
---|---|
author | Jardillier, Rémy Koca, Dzenis Chatelain, Florent Guyon, Laurent |
author_facet | Jardillier, Rémy Koca, Dzenis Chatelain, Florent Guyon, Laurent |
author_sort | Jardillier, Rémy |
collection | PubMed |
description | BACKGROUND: Prediction of patient survival from tumor molecular ‘-omics’ data is a key step toward personalized medicine. Cox models performed on RNA profiling datasets are popular for clinical outcome predictions. But these models are applied in the context of “high dimension”, as the number p of covariates (gene expressions) greatly exceeds the number n of patients and e of events. Thus, pre-screening together with penalization methods are widely used for dimensional reduction. METHODS: In the present paper, (i) we benchmark the performance of the lasso penalization and three variants (i.e., ridge, elastic net, adaptive elastic net) on 16 cancers from TCGA after pre-screening, (ii) we propose a bi-dimensional pre-screening procedure based on both gene variability and p-values from single variable Cox models to predict survival, and (iii) we compare our results with iterative sure independence screening (ISIS). RESULTS: First, we show that integration of mRNA-seq data with clinical data improves predictions over clinical data alone. Second, our bi-dimensional pre-screening procedure can only improve, in moderation, the C-index and/or the integrated Brier score, while excluding irrelevant genes for prediction. We demonstrate that the different penalization methods reached comparable prediction performances, with slight differences among datasets. Finally, we provide advice in the case of multi-omics data integration. CONCLUSIONS: Tumor profiles convey more prognostic information than clinical variables such as stage for many cancer subtypes. Lasso and Ridge penalizations perform similarly than Elastic Net penalizations for Cox models in high-dimension. Pre-screening of the top 200 genes in term of single variable Cox model p-values is a practical way to reduce dimension, which may be particularly useful when integrating multi-omics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10117-1. |
format | Online Article Text |
id | pubmed-9533541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95335412022-10-06 Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening Jardillier, Rémy Koca, Dzenis Chatelain, Florent Guyon, Laurent BMC Cancer Research BACKGROUND: Prediction of patient survival from tumor molecular ‘-omics’ data is a key step toward personalized medicine. Cox models performed on RNA profiling datasets are popular for clinical outcome predictions. But these models are applied in the context of “high dimension”, as the number p of covariates (gene expressions) greatly exceeds the number n of patients and e of events. Thus, pre-screening together with penalization methods are widely used for dimensional reduction. METHODS: In the present paper, (i) we benchmark the performance of the lasso penalization and three variants (i.e., ridge, elastic net, adaptive elastic net) on 16 cancers from TCGA after pre-screening, (ii) we propose a bi-dimensional pre-screening procedure based on both gene variability and p-values from single variable Cox models to predict survival, and (iii) we compare our results with iterative sure independence screening (ISIS). RESULTS: First, we show that integration of mRNA-seq data with clinical data improves predictions over clinical data alone. Second, our bi-dimensional pre-screening procedure can only improve, in moderation, the C-index and/or the integrated Brier score, while excluding irrelevant genes for prediction. We demonstrate that the different penalization methods reached comparable prediction performances, with slight differences among datasets. Finally, we provide advice in the case of multi-omics data integration. CONCLUSIONS: Tumor profiles convey more prognostic information than clinical variables such as stage for many cancer subtypes. Lasso and Ridge penalizations perform similarly than Elastic Net penalizations for Cox models in high-dimension. Pre-screening of the top 200 genes in term of single variable Cox model p-values is a practical way to reduce dimension, which may be particularly useful when integrating multi-omics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10117-1. BioMed Central 2022-10-05 /pmc/articles/PMC9533541/ /pubmed/36199072 http://dx.doi.org/10.1186/s12885-022-10117-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jardillier, Rémy Koca, Dzenis Chatelain, Florent Guyon, Laurent Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
title | Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
title_full | Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
title_fullStr | Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
title_full_unstemmed | Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
title_short | Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
title_sort | prognosis of lasso-like penalized cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533541/ https://www.ncbi.nlm.nih.gov/pubmed/36199072 http://dx.doi.org/10.1186/s12885-022-10117-1 |
work_keys_str_mv | AT jardillierremy prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening AT kocadzenis prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening AT chatelainflorent prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening AT guyonlaurent prognosisoflassolikepenalizedcoxmodelswithtumorprofilingimprovespredictionoverclinicaldataaloneandbenefitsfrombidimensionalprescreening |